OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Eli Lilly & Co/  US5324571083  /

Cboe Europe DXE
2024-07-26  5:28:02 PM Chg. -14.80 Volume Bid5:30:00 PM Ask5:29:51 PM Market Capitalization Dividend Y. P/E Ratio
752.80EUR -1.93% 295
Turnover: 208,730.35		 -Bid Size: - -Ask Size: - 704.3 bill.EUR - -
TeleTrader 07-08 Eli Lilly launches $3.2B tender offer for Morphic
TeleTrader 07-02 US FDA approves Eli Lilly's Alzheimer's drug
GlobeNewswire 07-01 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire 06-28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...
TeleTrader 06-25 Lilly partners with OpenAI to combat drug-resistance bacteria
GlobeNewswire 06-21 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 06-19 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 06-17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 06-17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 06-14 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 06-12 US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 06-11 Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...
GlobeNewswire 06-11 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 06-11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
TeleTrader 06-10 FDA advisors endorse Eli Lilly's Alzheimer's drug
Newsfile Corp 06-10 Guest Invitation to Momentum AI Summit in July
GlobeNewswire 06-10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 06-10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 06-06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire 06-06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
TeleTrader 06-05 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 06-04 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire 06-03 BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire 06-03 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine